Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
about
ATP-dependent chromatin remodeling complexes as novel targets for cancer therapyInsights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesisThe E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesisHeterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract.Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex.LoxP-FRT Trap (LOFT): a simple and flexible system for conventional and reversible gene targetingThe human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genesHMGB1 in health and disease.Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.Expression of BAF57 in ovarian cancer cells and drug sensitivity.RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients.Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.Hic-5 is a transcription coregulator that acts before and/or after glucocorticoid receptor genome occupancy in a gene-selective manner.AR function in promoting metastatic prostate cancerAberrant BAF57 signaling facilitates prometastatic phenotypes.Epigenomic regulation of oncogenesis by chromatin remodeling.The developmental and pathogenic roles of BAF57, a special subunit of the BAF chromatin-remodeling complex.Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.Linking the SWI/SNF complex to prostate cancer.Genetics and biology of prostate cancer
P2860
Q26849467-98DE7164-9D2D-4702-9A1F-2F9C3AC08E9EQ28571851-75E04F13-9ECE-49A2-A15A-55B320D19F4FQ28593902-C55EA60F-2272-45DF-9C43-C96C94818C9EQ33578231-19B2AF14-9FC6-4A7A-8D28-A2E183A44010Q33891958-1B93D9DE-DB94-41C4-9418-F86704BD2457Q34031869-3F9EBF3E-3AF9-4D49-9963-EB3549A77A92Q34285213-8FD5B281-C2B9-45B8-B13C-DAE33FE0A21AQ34496695-38AB861C-CB92-49FF-9072-EA75E1B2C223Q34606841-836592FE-5D62-4BAA-AC20-1A13A47E55D6Q34622835-2B5ECE21-9AA5-4018-9165-5EFDAB4238A7Q34624275-5F4CFBC9-9B7E-4B0C-BE67-AB797DCE8036Q34992490-51FCE135-82CF-4516-9EC3-308785855FEFQ35538429-DB8DE87F-95FF-40E4-BCBE-5C79F08C9440Q36025180-407196A1-E6C0-4600-A80B-63DC9C75CF15Q36027031-7BD17E64-2F4C-4EEF-92F2-3CC09A84ECF6Q36252546-2B4C9F10-8AE5-4A23-B0CE-7A4B1E627C6CQ37210875-56943600-22BF-451F-ACFF-4C41D0B5D92CQ37472232-7E7D04E8-F13F-4760-8A0B-FFCE24E49A3FQ37618471-EA418505-AA33-4F8E-B020-0F07ED118F32Q37659745-CFB6141B-9BB0-4338-A58E-2C1CBBF1050CQ38178555-B4AFADDF-7FC4-47B6-A33F-B6B5DEA945BCQ38317088-4C42407C-6868-43FF-9401-37C63FBE3321Q38709544-8C1E0A0E-9E0C-4482-B87B-9400DD544D79Q38826541-50CDD6DD-D591-404A-A67E-7DE0349A6400Q38958606-ABC3FC82-C4B8-4CF1-8E78-884620593B8BQ39439753-B0537D28-BBAD-4D3E-B6B9-F2CEDBACC9B7Q39628604-F46E7981-019F-4572-A594-E1C1279B5AF8Q39852952-56CB82DA-C54B-4382-842C-E1926D60B028Q39874231-8FA069AB-8C61-4A30-85F1-E5637DDC5988Q52644728-D651C69B-F9E0-4905-BF08-DE0743986AB1Q57106917-164A0A62-E1BC-4DED-98AA-BE14C1092037
P2860
Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Targeting the BAF57 SWI/SNF su ...... ol androgen receptor activity.
@en
type
label
Targeting the BAF57 SWI/SNF su ...... ol androgen receptor activity.
@en
prefLabel
Targeting the BAF57 SWI/SNF su ...... ol androgen receptor activity.
@en
P2093
P2860
P1433
P1476
Targeting the BAF57 SWI/SNF su ...... ol androgen receptor activity.
@en
P2093
Ankur Sharma
Annemie Haelens
Clay E S Comstock
Kevin A Link
Khanh H Cao
Monica P Revelo
Nathan Powers
Sonia Godoy-Tundidor
Sucharitha Balasubramaniam
P2860
P304
P356
10.1158/0008-5472.CAN-07-6392
P407
P577
2008-06-01T00:00:00Z